Centese Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $250K

  • Investors
  • 13

Centese General Information

Description

Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery. The company's technology uses integrated sensors, algorithms, and a small battery-powered controller to monitor blood drainage and other fluids, enabling patients to recover quickly and providing clinicians with reliable data to make informed decisions.

Contact Information

Website
www.centese.com
Formerly Known As
Esculon
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4156 South 52nd Street
  • Omaha, NE 68117
  • United States
+1 (888)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Manufacturing, HealthTech
Corporate Office
  • 4156 South 52nd Street
  • Omaha, NE 68117
  • United States
+1 (888)

Centese Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Centese Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 26-May-2026 $250K Completed Generating Revenue
10. Later Stage VC 12-May-2025 Completed Generating Revenue
9. Later Stage VC (Series B1) 20-Nov-2023 Completed Generating Revenue
8. Later Stage VC (Series B) 01-Nov-2021 Completed Generating Revenue
7. Later Stage VC (Series B) 13-Mar-2020 Completed Generating Revenue
6. Early Stage VC (Series A) 27-Nov-2017 Completed Generating Revenue
5. Grant 21-Apr-2017 Completed Generating Revenue
4. Grant 24-Mar-2017 Completed Generating Revenue
3. Grant 10-Jun-2016 $180K Completed Generating Revenue
2. Grant 01-Jan-2016 $97.5K Completed Generating Revenue
To view Centese’s complete valuation and funding history, request access »

Centese Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-1
Series B-3
Series B-2 70,283,606 $0.000010 $0.07 $0.07 1x $0.07 13.53%
Series A 40,141,298 $0.000010 $0.08 $0.08 1x $0.08 7.73%
To view Centese’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Centese Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Centese Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4724134-A1 Devices and methods for managing chest or wound drainage Pending 11-Jul-2023
US-20260108668-A1 Devices and methods for managing chest or wound drainage Pending 11-Jul-2023
WO-2025015038-A1 Devices and methods for managing chest or wound drainage Inactive 11-Jul-2023
US-20220355018-A1 Devices and methods for managing chest or wound drainage Pending 25-Jan-2020
WO-2021150999-A1 Devices and methods for managing chest or wound drainage Inactive 25-Jan-2020 A61M1/74
To view Centese’s complete patent history, request access »

Centese Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Centese Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
HBS Alumni Angels of Greater New York Angel Group Minority
New York Angels Angel Group
Nebraska Angels Angel Group Minority
Proven Ventures Venture Capital Minority
Accuryn VC-Backed Company Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Centese FAQs

  • When was Centese founded?

    Centese was founded in 2015.

  • Where is Centese headquartered?

    Centese is headquartered in Omaha, NE.

  • What is the size of Centese?

    Centese has 17 total employees.

  • What industry is Centese in?

    Centese’s primary industry is Surgical Devices.

  • Is Centese a private or public company?

    Centese is a Private company.

  • What is Centese’s current revenue?

    The current revenue for Centese is .

  • How much funding has Centese raised over time?

    Centese has raised $30.8M.

  • Who are Centese’s investors?

    HBS Alumni Angels of Greater New York, New York Angels, Nebraska Angels, Proven Ventures, and Accuryn are 5 of 13 investors who have invested in Centese.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process